LEAPS influenza A virus vaccine-H1N1 in patients with influenza A virus H1N1 subtype

Trial Profile

LEAPS influenza A virus vaccine-H1N1 in patients with influenza A virus H1N1 subtype

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2009

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Nov 2009 Status changed from planning to recruiting. CEL SCI announced in a media release that the Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for this clinical study to proceed.
    • 22 Sep 2009 New trial record.
    • 16 Sep 2009 US FDA approval for trial initiation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top